US$ 28.81
retatrutide phase 2 weight loss Survodutide vs. for The future of weight loss
Description
Brand Names and Availability Tirzepatide is marketed as Mounjaro for type 2 diabetes and Zepbound for weight loss
Ongoing Phase 3 trials are expected to provide more robust safety information

It remains experimental and is not FDA-approved as a therapy

Metformin may be a better fit for those with prediabetes or insulin resistance, as it helps the body process glucose more efficiently

Retatrutide for the treatment of obesity: A phase 2, randomized, double-blind, placebo-controlled trial

GLP-1 receptor agonists deliberately slow gastric emptying as part of their mechanism of action
